In a multinational , multicenter , double-blind , placebo-controlled , randomized trial , patients with symptoms and signs of STEMI and transferred to a hospital for primary PCI will be randomized in a 1:1 fashion to intravenous metoprolol ( 5 mg twice daily ) administration or placebo .